文献速递甲状腺疾病

美国癌症联合委员会第8版甲状腺乳头状癌T分期系统分析

An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

该回顾性分析纳入577例甲状腺乳头状癌患者,比较AJCC第7版与第8版T分期的无病生存预后表现。在≥55岁无宏观甲状腺外侵犯或远处转移的患者中,第8版劣于第7版(C指数0.67 vs 0.76),显微镜下甲状腺外侵犯与无病生存降低相关(HR 2.8)。

要点

  • 在≥55岁无宏观甲状腺外侵犯或远处转移者中,pT8预后表现劣于pT7。
  • 该亚组中显微镜下甲状腺外侵犯与无病生存降低相关(HR 2.8,95%CI 1.5-5.2,P=0.002)。
  • 整体人群中pT7与pT8的预后表现相似。

核心结论

  • 在本队列中,≥55岁无宏观甲状腺外侵犯或远处转移且T分类影响TNM分期的患者中,pT8劣于pT7。
  • 显微镜下甲状腺外侵犯与该亚组其他不良预后因素及无病生存降低强烈相关,无论肿瘤大小,可能有效反映疾病生物学行为,不论其是否为独立预后因素。

研究设计与样本

  • 回顾性分析577例甲状腺乳头状癌患者的无病生存,比较pT8与pT7,采用AIC、Harrell C指数和PVE评价。

主要发现

  • 105例AJCC7 T3疾病中74例被降期。
  • 整体上pT7与pT8的预后表现相似。
  • ≥55岁无宏观甲状腺外侵犯或远处转移者中,pT8较pT7的AIC更高、C指数更低(0.67 vs 0.76)、PVE更低(30% vs 45%)。
  • 该亚组中显微镜下甲状腺外侵犯与无病生存降低相关(HR 2.8;95%CI 1.5-5.2;P=0.002),无论肿瘤大小。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American Joint Committee on Cancer (AJCC) removed microscopic extrathyroidal extension (ETE) from the 8th edition T staging for papillary thyroid cancer (PTC) based on increasing evidence that it is not an independent prognostic factor. OBJECTIVES: We compared the prognostic performance of AJCC 7th (pT7) and 8th (pT8) edition T stage systems, particularly in patients ≥55 years old without macroscopic ETE or distant metastases in whom T classification affects AJCC Tumor Node Metastasis (TNM) stage. METHOD: A retrospective analysis of disease-free survival (DFS) in 577 patients with PTC comparing pT8 vs pT7 using the Akaike information criterion (AIC), Harrell's C-index, and Proportion of Variation Explained (PVE). RESULTS: Of 105 patients with AJCC7 T3 disease, 74 were down-staged. Overall, the prognostic performance of pT7 and pT8 was similar. However, in patients ≥55 years old without macroscopic ETE or distant metastases, pT8 was inferior to pT7 on the basis of higher AIC, lower C-index (0.67 vs 0.76), and lower PVE (30% vs 45%). In this subset, microscopic ETE was associated with multiple other adverse prognostic features and reduced DFS (hazard ratio, 2.8; 95% confidence interval, 1.5 to 5.2; P = 0.002), irrespective of tumor size. DISCUSSION: In our cohort, pT8 was inferior to pT7 in patients ≥55 years old without macroscopic ETE or distant metastases in whom T classification affects TNM stage. Microscopic ETE was strongly associated with other adverse prognostic factors and reduced DFS in this patient subgroup and may be an effective surrogate for disease biology in PTC, irrespective of whether it is an independent prognostic factor.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Tran B, Roshan D, Abraham E, et al. An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2018. PMID: 29672723. doi:10.1210/jc.2017-02551

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。